免疫检查点阻断通过扩增效应 CD8⁺ T 细胞克隆增强淋巴细胞清除性化疗诱导的抗肿瘤免疫
Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy-Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Is There a Relationship Between TILs and Regression in Melanoma?
Is There a Relationship Between TILs and Regression in Melanoma?
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
回归与 TILs 高度相关,但在黑色素瘤患者中,只有 TILs 与 SLN 转移和 OS 显著相关,而回归则不然。回归对结局的影响最终似乎取决于 TILs 的缺失或存在。
TIL(肿瘤浸润淋巴细胞)(TILs)与黑色素瘤消退之间的关系尚不清楚。本报告描述了一项大型多中心研究,评估TILs与消退之间的关联。
前哨淋巴结工作组数据库查询了1993年至2018年间具有TIL和消退数据的病例。临床病理因素与消退和TIL状态、前哨淋巴结(SLN)状态以及总生存期(OS)相关。
该研究纳入了2450例患者。在1811例(73.9%)中,存在TILs,其中328例(18.1%)伴有消退,而在639例无TILs的病例中,49例(7.7%)伴有消退。TILs的存在与消退显著相关(p < 0.0001),也与SLN阴性显著相关(p < 0.05)。然而,当按消退状态对TILs进行分层时,只有TILs和消退同时缺失或同时存在才与SLN转移显著相关(p = 0.038)。尽管TILs的存在与OS相关(p < 0.05),但消退状态本身与OS无关(分别为p = 0.2058和0.252)。此外,当按消退状态对TILs进行分层时,只有存在TILs伴或不伴消退与OS改善显著相关(分别为p = 0.0081和0.0137),相比之下TILs和消退均缺失;对于有或无TILs的患者,消退状态对OS无显著影响(分别为p = 0.2314和0.65)。
The relationship between tumor-infiltrating lymphocytes (TILs) and regression in melanoma is unknown. This report describes a large multicenter study assessing the association between TILs and regression.
The Sentinel Lymph Node Working Group database was queried from 1993 to 2018 for cases with TILs and regression data. Clinicopathologic factors were correlated with regression and TIL status, sentinel lymph node (SLN) status, and overall survival (OS).
The study enrolled 2450 patients. In 1811 cases, TILs (73.9%) were present, with regression present in 328 of these 1811 (18.1%) cases and in 49 (7.7%) of 639 cases without TILs. The presence of TILs was significantly associated with regression (p < 0.0001) as well as a negative SLN (p < 0.05). However, when TILs were stratified by regression status, only absence or presence of both TILs and regression were significantly associated with SLN metastases (p = 0.038). Although the presence of TILs was associated with OS (p < 0.05), regression status by itself was not (p = 0.2058 and 0.252, respectively). Furthermore, when TILs were stratified by regression status, only the presence of TILs with or without regression was significantly associated with improved OS (p = 0.0081 and 0.0137, respectively) versus the absence of both TILs and regression, with regression status not significantly affecting OS for patients with or without TILs (p = 0.2314 and 0.65, respectively).
Regression is highly correlated with TILs, but only TILs are significantly associated with SLN metastasis and OS in melanoma patients, whereas regression is not. The impact of regression on outcomes ultimately appears dependent upon the absence or presence of TILs.
MEMBER ACCOUNT
登录成功会直接打开下一页。